Uflex (500148) Q3 25/26 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 25/26 earnings summary
16 Feb, 2026Executive summary
India's largest integrated flexible packaging company faced macro headwinds from US tariff uncertainty, GST transition, and subdued global demand, impacting volumes and pricing.
Despite challenges, the company focused on operational discipline, product mix improvement, cost optimization, and sustainability initiatives.
Strategic capex projects in Egypt (aseptic packaging), Mexico (WPP bags), and India (recycling, BOPP line) are nearing completion, expected to boost capacity and profitability.
Unaudited standalone and consolidated financial results for the quarter and nine months ended 31 December 2025 were approved and reviewed by the Board and Audit Committee, including subsidiaries and associates.
Financial highlights
Nine-month FY26 revenue reached INR 114.16 billion, up 0.8% year-over-year; Q3 revenue was INR 36.33 billion, down 3.8% year-over-year due to volume softness and pricing pressure.
Normalized EBITDA for nine months was INR 13 billion, down 9.6% year-over-year, with margin at 11.4%; Q3 normalized EBITDA rose 12.8% sequentially to INR 4.40 billion.
Q3 PAT was INR 361 million, with EPS at INR 5.01; 9MFY26 PAT was INR 1.21 billion, swinging from a loss last year.
Consolidated Q3 FY26 revenue was ₹361,201 lakhs, with net profit at ₹3,615 lakhs; standalone Q3 revenue was ₹181,595 lakhs.
Net debt as of Dec 2025 was Rs. 81,810 million; net debt/normalized EBITDA at 4.72x.
Outlook and guidance
FY26 EBITDA margin expected around 12%, with EBITDA guidance of INR 1,800–1,850 crore reaffirmed.
Margin improvement anticipated in FY27, driven by better product mix and price realization.
Management expects improved utilization and sales momentum in Q4 FY26 as inventory destocking eases and import pressures moderate.
Aseptic packaging business projected to reach 8.5 billion packs in FY26, with further growth as Egypt plant ramps up.
Management remains confident that no material tax liability will arise from ongoing tax proceedings.
Latest events from Uflex
- Double-digit revenue and EBITDA growth, margin expansion, and strong outlook despite currency losses.500148
Q1 24/252 Feb 2026 - Strong revenue growth and global expansion offset by margin pressures from currency losses.500148
Q2 24/2513 Jan 2026 - Q1 FY26 revenue and profit rose, with expansion and regulatory shifts driving future growth.500148
Q1 25/2623 Nov 2025 - Q3 FY25 delivered strong growth, margin gains, and major investments for future expansion.500148
Q3 24/2521 Nov 2025 - Turnaround year with strong profit, double-digit growth, and major global expansion.500148
Q4 24/2519 Nov 2025 - Q2 FY26 saw flat revenue, modest profit, and new capacity expansion amid regulatory headwinds.500148
Q2 25/2614 Nov 2025